• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.62% Nasdaq Up 0.35%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    87.80 Up 0.55(0.63%) Feb 10, 4:00PM EST
    |After Hours : 87.50 Down 0.30 (0.34%) Feb 10, 7:50PM EST
    Prev Close:87.25
    Open:88.69
    Bid:87.00 x 300
    Ask:87.74 x 100
    1y Target Est:118.63
    Beta:1.40682
    Earnings Date:Apr 28 - May 2 (Est.)
    Day's Range:87.54 - 89.85
    52wk Range:81.89 - 123.37
    Volume:13,462,287
    Avg Vol (3m):10,966,700
    Market Cap:124.85B
    P/E (ttm):7.37
    EPS (ttm):11.91
    Div & Yield:1.72 (2.02%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GILDUp 0.63%124.85B
    GSKDown 0.53%94.69B
    PFEUp 1.34%182.06B

    Key Statistics

    Forward P/E (1 yr):7.00
    P/S (ttm):3.80
    Ex-Dividend Date:14-Dec-15

    Analysts

    Annual EPS Est (Dec-16) :12.25
    Quarterly EPS Est (Mar-16) :3.08
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):0.72

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback